|
Index of reports
> Cases with Pyrexia (15)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epirubicin side effects in 57 year old female
Reported by a consumer/non-health professional from Spain on 2012-07-27
Patient: 57 year old female
Reactions: Pyrexia, Neutropenia, Hidradenitis, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Start date: 2006-08-23
End date: 2006-11-02
Docetaxel
Indication: Breast Cancer
Start date: 2006-08-23
End date: 2006-11-02
Other drugs received by patient: Hipoartel; Simvastatin; Ceftazidime; Pantoprazole
Possible Epirubicin side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20
Patient: 44 year old female, weighing 55.5 kg (122.1 pounds)
Reactions: Abdominal Pain, Intestinal Ischaemia, Colitis Ischaemic, White Blood Cell Count Decreased, Vomiting, Blood Creatine Phosphokinase Increased, Gastrointestinal Necrosis, Pyrexia, Multi-Organ Failure, Diarrhoea, GAS Gangrene, Heart Rate Increased, Bone Marrow Failure, Neutropenia, Clostridial Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 7 cycles, total 4 courses
Indication: Breast Cancer
Start date: 2011-07-22
End date: 2011-09-22
Epirubicin
Dosage: 7 cycles, total 4 courses
Indication: Breast Cancer
Start date: 2011-07-22
End date: 2011-09-22
Taxotere
Dosage: 4 cycles, total 3 courses, dose taken once daily
Indication: Breast Cancer
Start date: 2011-10-14
End date: 2011-11-25
Other drugs received by patient: Leucon; Lorazepam; Decadron Phosphate; Lorazepam; Kytril; Prochlorperazine; Kytril; Cepharanthin; Decadron Phosphate; Marzulene S
Possible Epirubicin side effects in 68 year old female
Reported by a physician from Japan on 2012-06-15
Patient: 68 year old female, weighing 39.9 kg (87.8 pounds)
Reactions: White Blood Cell Count Decreased, Dyspnoea, Nausea, Hypotension, Tachycardia, Toxic Epidermal Necrolysis, Pyrexia, Haemoglobin Decreased, Respiratory Failure, Circulatory Collapse, Neutropenia, Rash Vesicular, Oxygen Saturation Decreased, Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Start date: 2012-02-28
End date: 2012-02-28
Epirubicin
Indication: Breast Cancer
Start date: 2012-02-28
End date: 2012-02-28
Possible Epirubicin side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-13
Patient: 67 year old female
Reactions: Acute Myeloid Leukaemia, Pyrexia, Papule
Drug(s) suspected as cause:
Idarubicin HCL
Dosage: (12 mg/m2)
Indication: Acute Myeloid Leukaemia
Cyclophosphamide
Dosage: (df), (df), (df), (df)
Indication: Breast Cancer
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Trastuzumab (Trastuzumab)
Dosage: (1 df 3x/week)
Indication: Breast Cancer
Mitoxantrone
Dosage: (7 mg/m2)
Indication: Acute Myeloid Leukaemia
Epirubicin
Dosage: (df), (df), (df), (df)
Indication: Breast Cancer
Docetaxel
Dosage: (df), (df), (df), (df)
Indication: Breast Cancer
Fluorouracil
Dosage: (df), (df), (df), (df)
Indication: Breast Cancer
Tegafur Uracil (Tegafur / Uracil)
Dosage: (df oral)
Administration route: Oral
Indication: Colon Cancer
Possible Epirubicin side effects in female
Reported by a physician from Germany on 2012-05-18
Patient: female, weighing 110.0 kg (242.0 pounds)
Reactions: Vomiting, Nasopharyngitis, Nausea, Diarrhoea, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: 200 mg, unk
Start date: 2010-11-05
End date: 2011-01-07
NO Treatment Received
Dosage: no treatment
Indication: Breast Cancer
Fluorouracil
Dosage: 100 mg, unk
Start date: 2010-11-05
End date: 2011-01-07
Cyclophosphamide
Dosage: 1000 mg, unk
Start date: 2010-11-05
End date: 2011-01-07
Other drugs received by patient: Paracodin Bitartrate TAB; Cefuroxime; Acetylcysteine; Allopurinol
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-18
Patient: 49 year old female
Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Multi-Organ Failure, Death, Lymphocytosis, Dizziness, Asthenia, Septic Shock, Leukocytosis, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytoxan
Dosage: 100 mg, unk
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Epirubicin
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Fluorouracil
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-15
Patient: 49 year old female
Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Lymphocytosis, Multi-Organ Failure, Death, Dizziness, Septic Shock, Asthenia, Leukocytosis, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Fluorouracil
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Epirubicin
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Possible Epirubicin side effects in 68 year old female
Reported by a physician from Japan on 2012-05-04
Patient: 68 year old female, weighing 39.9 kg (87.8 pounds)
Reactions: White Blood Cell Count Decreased, Dyspnoea, Nausea, Hypotension, Tachycardia, Toxic Epidermal Necrolysis, Pyrexia, Haemoglobin Decreased, Respiratory Failure, Circulatory Collapse, Neutropenia, Rash Vesicular, Oxygen Saturation Decreased, Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Start date: 2012-02-28
End date: 2012-02-28
Cyclophosphamide
Indication: Breast Cancer
Start date: 2012-02-28
End date: 2012-02-28
Possible Epirubicin side effects in male
Reported by a individual with unspecified qualification from Italy on 2012-04-04
Patient: male
Reactions: Caesarean Section, Ventricular Hypokinesia, Foetal Exposure During Pregnancy, Pyrexia, Klebsiella Test Positive, Staphylococcus Test Positive, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Possible Epirubicin side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-23
Patient: male
Reactions: Ventricular Hypokinesia, Foetal Exposure During Pregnancy, Pyrexia
Drug(s) suspected as cause:
Epirubicin
Possible Epirubicin side effects in female
Reported by a physician from Switzerland on 2012-03-02
Patient: female, weighing 41.0 kg (90.2 pounds)
Reactions: Febrile Neutropenia, Pyrexia, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: 75mgm2 cyclic
Indication: Neoplasm
Start date: 2010-04-27
Votrient
Dosage: 400mg per day
Administration route: Oral
Indication: Neoplasm
Start date: 2010-04-28
Other drugs received by patient: Dexamethasone; Dexamethasone
Possible Epirubicin side effects in 18 year old female
Reported by a physician from India on 2012-02-21
Patient: 18 year old female
Reactions: Enterococcal Bacteraemia, Encephalopathy, Pyrexia, Leukaemia Recurrent, B Precursor Type Acute Leukaemia, Venoocclusive Liver Disease, Sepsis, Tachypnoea, Pleural Effusion, Acute Hepatic Failure, Gallbladder Disorder
Drug(s) suspected as cause:
Vincristine
Indication: Acute Lymphocytic Leukaemia
Elspar
Indication: Acute Lymphocytic Leukaemia
Epirubicin
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Total Parenteral Nutrition (Tpn) (Tpn); Norethindrone
Possible Epirubicin side effects in 38 year old female
Reported by a individual with unspecified qualification from United States on 2012-01-27
Patient: 38 year old female
Reactions: Confusional State, Vomiting, Gastrointestinal Toxicity, Neurological Decompensation, Nausea, Oesophageal Fistula, FAT Embolism, Pyrexia, Haematemesis, Grand MAL Convulsion, Cerebral Artery Embolism, Brain Oedema, Intracranial Pressure Increased, Heart Injury, Gastrointestinal Injury
Adverse event resulted in: death
Drug(s) suspected as cause:
Oxaliplatin
Indication: Oesophageal Carcinoma
Epirubicin
Indication: Oesophageal Carcinoma
Cisplatin
Indication: Oesophageal Carcinoma
Fluorouracil
Indication: Oesophageal Carcinoma
Possible Epirubicin side effects in 38 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-25
Patient: 38 year old female
Reactions: Confusional State, Fistula, Vomiting, Nausea, Neurological Decompensation, Gastrointestinal Toxicity, Pyrexia, Grand MAL Convulsion, AIR Embolism, Brain Oedema, Intracranial Pressure Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Fluorouracil
Dosage: continuous infusion
Therapeutic Radiopharmaceuticals
Dosage: 50 gy given in 28 fraction
Oxaliplatin
Dosage: 2-hour duration
Fluorouracil
Dosage: continuous infusion
Fluorouracil
Dosage: two cycles given, consolidation therapy
Cisplatin
Dosage: two cycles given, consolidation therapy
Epirubicin
Oxaliplatin
Dosage: 2-hour duration
Epirubicin
Possible Epirubicin side effects in 18 year old female
Reported by a health professional (non-physician/pharmacist) from India on 2011-10-18
Patient: 18 year old female
Reactions: Jaundice, Enterococcal Infection, Encephalopathy, Pyrexia, Ascites, Weight Increased, Hepatomegaly, Venoocclusive Liver Disease, Oedema Peripheral, Acute Hepatic Failure, Pleural Effusion, Tachypnoea, Gallbladder Disorder
Drug(s) suspected as cause:
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Epirubicin
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Indication: Acute Lymphocytic Leukaemia
|
